| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $28.5M | +76.5% |
| SG&A Expense | $12.8M | +173.2% |
| Operating Income | -$42.3M | -95.9% |
| Income Tax | $0 | — |
| Net Income | -$41.0M | -90.1% |
| EPS (Basic) | -$2.79 | +73.8% |
| EPS (Diluted) | -$2.79 | +73.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.2M | +125.0% |
| Current Assets | $98.6M | +64.1% |
| Total Assets | $102.6M | +57.0% |
| Current Liabilities | $7.2M | +111.7% |
| Total Liabilities | $7.2M | +110.9% |
| Stockholders' Equity | $95.4M | +301.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.5M | -63.4% |
| Investing Cash Flow | -$21.8M | +56.5% |
| Financing Cash Flow | $70.4M | -10.4% |